Increased risk of breast cancer in first-degree relatives of Crohn's disease patients. An IG-IBD study

Digestive and Liver Disease

Volumn 38, Issue 1, 2006, Pages 18-23

  Riegler, G ^a   Caserta, L ^a   Castiglione, F ^b   Esposito, I ^a   Valpiani, D ^c   Annese, V ^d   Zoli, G ^e   Gionchetti, P ^f   Viscido, A ^g   Sturniolo, G C ^h   Rispo, A ^b   De Filippo, F R ^a   de Leone, A ^a   Carratu, R ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c MORGAGNI PIERANTONI HOSPITAL   (Italy)

^d IRCSS General Hospital   (Italy)

^e Diagnosis and Therapy   (Italy)

^f UNIVERSITY OF BOLOGNA   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h UNIVERSITY OF PADOVA   (Italy)

Author keywords

Breast cancer; Crohn's disease; Malignancies; Risk factors

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; FEMALE; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTHER; OUTPATIENT; PHENOTYPE; PREVALENCE; RELATIVE; BREAST TUMOR; GENETIC PREDISPOSITION; GENETICS; RISK FACTOR;

ADULT; BREAST NEOPLASMS; CROHN DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; RISK FACTORS;

EID: 33744772940     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2005.07.006     Document Type: Article

References (26)

1. Ekbom A., Helmick C., Zack M., and Adami H.O. Ulcerative colitis and colorectal cancer. A population-based cohort study. N Engl J Med 323 (1990) 1228-1233
2. Karlen P., Lofberg R., Brostrom O., Leijonmarck C.E., Hellers G., and Persson P.G. Increased risk of cancer in ulcerative colitis: a population-based cohort study. Am J Gastroenterol 94 (1999) 1047-1052
3. Gyde S.N., Prior P., Macartney J.C., Thompson H., Waterhouse J.A.H., and Allan R.N. Malignancy in Crohn's disease. Gut 21 (1980) 1024-1029
4. Gillen C.D., Andrews H.A., Prior P., and Allan R.N. Crohn's disease and colorectal cancer. Gut 35 (1994) 651-655
5. Ekbom A., Helmick C., Zack M., and Adami H.O. Increased risk of large bowel cancer in Crohn's disease with colonic involvement. Lancet 336 (1990) 357-359
6. Bernstein C.N., Blanchard J.F., Kliewer E., and Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91 (2001) 854-862
7. Jess T., Winther K.V., Munkholm P., Langholz E., and Binder V. Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment Pharmacol Ther 19 (2004) 287-293
8. Greenstein J., Gennuso R., Sachar D.B., Heimann T., Smith H., Janowitz H.D., et al. Extraintestinal cancers in inflammatory bowel disease. Cancer 56 (1985) 2914-2921
9. Mir-Madjlessi S.H., Farmer R.G., Easley K.A., and Beck G.J. Colorectal and extracolonic malignancy in ulcerative colitis. Cancer 58 (1986) 1569-1574
10. Ekbom A., Helmick C., Zack M., and Adami H.O. Extracolonic malignancies in inflammatory bowel disease. Cancer 67 (1991) 2015-2019
11. Rhodes J.M. Unifying hypothesis for inflammatory bowel disease and associated colon cancer: sticking the pieces together with sugar. Lancet 347 (1996) 40-44
12. Fonager K., Sorensen H.T., Mellemkjaer L., Olsen J.H., and Olsen J. Risk of colorectal cancer in relatives of patients with inflammatory bowel disease (Denmark). Cancer Causes Control 9 (1998) 389-392
13. Askling J., Dickman P.W., Karlen P., Brostrom O., Lapidus A., Lofberg R., et al. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study. Lancet 357 (2001) 262-266
14. Riegler G., Carratu R., Tartaglione M., Morace F., Manzione R., and Arimoli A. Prevalence and relative risk of malignancy in relatives of inflammatory bowel disease patients and control subjects. J Clin Gastroenterol 27 (1998) 211-214
15. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol 170 (1989) 2-6
16. Simmons J.D., Mullighan C., Welsh K.I., and Jewell D.P. Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut 47 (2000) 211-214
17. Csaszar A., and Abel T. Receptor polymorphisms and diseases. Eur J Pharmacol 414 (2001) 9-22
18. Hamajima N., and Yuasa H. Genetic polymorphisms related to interleukin-1 beta production and disease risk. Nippon Koshu Eisei Zasshi 50 (2003) 194-207
19. Satsangi J., Welsh K.I., Bunce M., Julier C., Farrant J.M., Bell J.I., et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 347 (1996) 1212-1217
20. Pokorny R.M., Hofmeister A., Galandiuk S., Dietz A.B., Cohen N.D., and Neibergs H.L. Crohn's disease and ulcerative colitis are associated with the DNA repair gene MLH1. Ann Surg 225 (1997) 718-723
21. Caruso M.L., Cristofaro G., and Lynch H.T. HNPCC-Lynch syndrome and idiopathic inflammatory bowel disease. A hypothesis on sharing of genes. Anticancer Res 17 (1997) 2647-2649
22. Timmer A., Sutherland L.R., and Martin F. Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. Gastroenterology 114 (1998) 1143-1150
23. Cottone M., Rosselli M., Orlando A., Oliva L., Puleo A., Cappello M., et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 106 (1994) 643-648
24. Marchbanks P.A., McDonald J.A., Wilson H.G., Folger S.G., Mandel M.G., Daling J.R., et al. Oral contraceptives and the risk of breast cancer. N Engl J Med 346 (2002) 2025-2032
25. Chlebowski R.T., et al., WHI Investigators. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. J Am Med Assoc 289 (2003) 3243-3253
26. Liu L., Wu K., Lin X., Yin W., Zheng X., Tang X., et al. Passive smoking and other factors at different periods of life and breast cancer risk in Chinese women who have never smoked-a case-control study in Chongqing, People's Republic of China. Asia Pac J Cancer Prev 1 (2000) 131